BUSINESS● LOW4d ago · Aug 28, 2026, 10:48 AM
Pfizer-backed Priovant wins FDA approval for lead asset
Seeking Alpha Tech · north america
Priovant, a company supported by Pfizer, has received FDA approval for its primary product. This marks a significant regulatory milestone for the pharmaceutical asset.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESS25m agoAustralia posts second-quarter growth of 2.1%, beating expectationsCNBCBUSINESS27m agoMongoDB projects fiscal 2027 revenue of $2.99B to $3.03B while raising Atlas growth outlook to ~27%Seeking Alpha TechBUSINESS28m agoLabor downplays impact of falling house - price forecastsdailyliberal.com.au · AustraliaBUSINESS28m agoOil giant Chevron to announce expanded operations in Venezuelawokv.com · United States